A carregar...
Immunotherapy in Head and Neck Squamous Cell Cancer
Prognosis in relapsed metastatic head and neck squamous cell cancer (RM-HNSCC) is dismal. Platinum based chemotherapy in combination with Cetuximab is used in first-line setting, while no further validated options are available at progression. Immunotherapy has produced durable clinical benefit in s...
Na minha lista:
| Publicado no: | Clin Exp Otorhinolaryngol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Society of Otorhinolaryngology-Head and Neck Surgery
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6222190/ https://ncbi.nlm.nih.gov/pubmed/29973040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21053/ceo.2018.00150 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|